Intravenous immunoglobulin: a safe option for treatment of steroid-resistant rejection in the presence of infection
- PMID: 15167606
- DOI: 10.1097/01.tp.0000122415.08639.53
Intravenous immunoglobulin: a safe option for treatment of steroid-resistant rejection in the presence of infection
Abstract
Management of recurrent allograft rejection is a risky proposition, especially in the presence of infections. Both steroids and antibody therapy worsen the infection risk. We successfully treated steroid-resistant rejection with intravenous immunoglobulin (IVIG) in two patients who had concomitant infections. IVIG should be considered the treatment of choice for management of steroid-resistant rejection in the presence of serious infection.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
